ArticleKidney international reports2025

Prospective Study on Individualized Dose Adjustment of Tolvaptan Based on Urinary Osmolality in Patients With ADPKD.

Paul Geertsema et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.